Pages that link to "Q41444263"

The following pages link to A cyclin-dependent kinase inhibitor, butyrolactone I, inhibits phosphorylation of RB protein and cell cycle progression. (Q41444263):

Displaying 11 items.

• The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2 (Q24561705) (← links)
• Cyclin-dependent kinase 5 is required for associative learning (Q28511889) (← links)
• Flow cytometry and cell sorting of heterogeneous microbial populations: the importance of single-cell analyses (Q34063938) (← links)
• The G1 phase Cdks regulate the centrosome cycle and mediate oncogene-dependent centrosome amplification (Q34573625) (← links)
• The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer (Q35157537) (← links)
• Four butyrolactones and diverse bioactive secondary metabolites from terrestrial Aspergillus flavipes MM2: isolation and structure determination. (Q35950974) (← links)
• Natural Compounds as Modulators of Cell Cycle Arrest: Application for Anticancer Chemotherapies. (Q39214217) (← links)
• Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2. (Q39715869) (← links)
• Mechanisms of action of the novel sulfonamide anticancer agent E7070 on cell cycle progression in human non-small cell lung cancer cells (Q40780019) (← links)
• Stat6 cooperates with Sp1 in controlling breast cancer cell proliferation by modulating the expression of p21(Cip1/WAF1) and p27 (Kip1). (Q51755890) (← links)
• Cyclin-Dependent Kinase 5 Inhibitor Butyrolactone I Elicits a Partial Agonist Activity of Peroxisome Proliferator-Activated Receptor γ (Q89698157) (← links)